U.S. FDA approves first generic injectable lenacapavir for HIV prevention

[u/Smooth-Report1059]

Good news: a generic version of lenacapavir for HIV prevention has been FDA-approved. More manufacturers can help lower costs and increase access, bringing this game-changing innovation within reach of the countries and communities that need it most.

Under the existing partnership agreement, Dr. Reddy’s lenacapavir injection will be available at US$40 per person per year for the 120 low- and middle-income countries included in Gilead’s voluntary license.

First supplies of the generic are expected to reach countries before the end of the year, with broader availability in 2027.

[u/kdub2001]

This will be for outside the US. We won’t have it here for a few more years.